+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024

  • ID: 4760920
  • Report
  • Region: Global
  • 133 Pages
  • Markets and Markets
1 of 6
The Cell-Based Assays Market is Projected to Reach USD 18.9 Billion by 2024 from USD 13.9 Billion in 2019, at a CAGR of 6.3%

FEATURED COMPANIES

  • Cell Biolabs, Inc.
  • Cisbio
  • Danaher Corporation
  • Ge Healthcare
  • Lonza Group Ltd.
  • Merck KGaA
  • MORE

Cell-based assays market to register a CAGR of 6.3% from 2019 to 2024

The cell-based assays market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing research funding, and the growth in the number of drug discovery activities. Emerging economies with growing R&D expenditures are also expected to provide opportunities for the growth of the market.

Services exhibited the highest CAGR over the forecast period.

By product & service, the cell-based assays market is segmented into consumables, instruments and services. Over the forecast period, the services segment accounted for the highest CAGR. The increased R&D investments and technological innovations in supportive processes such as high-throughput screening is driving the growth of this product & service segment.

Basic research held the significant share in the cell-based assays market in 2019

On the basis of application, the cell-based assays market is segmented into drug discovery, basic research and other research such as quality check among others. In 2019, the drug discovery segment accounted for the largest share of the cell-based assays market. The large share of this segment can be attributed to the rising adoption of in vitro testing over animal testing and increasing in R&D spending by biopharmaceutical companies.

Asia Pacific exhibited the highest CAGR over the forecast period

North America, which includes the US and Canada, accounted for the largest share of the cell-based assays market. The large share of this market segment can be attributed to the increasing drug discovery activities by pharmaceutical and biotechnology companies. In addition to this, consolidations between academic and government institutes with biopharmaceutical companies in the region are also driving the growth of this market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (35%), Europe (24%), Asia Pacific (25%), and RoW (16%)

Some of the major players in this market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US).

Research Coverage
This report studies the cell-based assays market based on products, applications, end users, and regions. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell-based assays market. The report forecasts the revenue of the market segments with respect to four major regions.
 
Reasons to Buy the Report:
The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the cell-based assays offered by the top 10 players in the cell-based assays market. The report analyzes the cell-based assays market by product, , end user, application, and region
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various cell-based assays across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell-based assays market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell-based assays market
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Cell Biolabs, Inc.
  • Cisbio
  • Danaher Corporation
  • Ge Healthcare
  • Lonza Group Ltd.
  • Merck KGaA
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Cell-Based Assays: Market Overview
4.2 Cell-Based Assays Market, By Product & Service and Application (2018)
4.3 Geographical Snapshot of the Cell-Based Assays Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Preference for Cell-Based Assays
5.2.1.2 Growing Research Funding
5.2.1.3 Growth in the Number of Drug Discovery Activities
5.2.2 Restraint
5.2.2.1 High Cost of Instruments and Restrictions on Reagent Use
5.2.3 Opportunities
5.2.3.1 High-Growth Asian Countries
5.2.3.2 Application of Novel Cell-Based Assays in Cancer Research

6 Cell-Based Assays Market, By Product & Service
6.1 Introduction
6.2 Consumables
6.2.1 Reagents
6.2.1.1 Reagents Have Widespread Usage in Life Sciences Due to Their Application in Immunology Research, Disease Research, and Cancer Diagnostics
6.2.2 Assay Kits
6.2.2.1 Reporter Gene Assays
6.2.2.1.1 Reporter Gene Assays Can Be Used With Limited Resources for the Establishment of Hts Platforms, Presenting Opportunities for Small Laboratories With Limited Resources
6.2.2.2 Second Messenger Assays
6.2.2.2.1 Second Messenger Assays Allow the Detection and Characterization of All Compound Classes - A Key Driver for Market Growth
6.2.2.3 Cell Growth Assays
6.2.2.3.1 Cell Viability and Cell Proliferation Assays are the Two Most Important in Vitro Quantification Techniques for Assessing Cell Growth
6.2.2.4 Cell Death Assays
6.2.2.4.1 Cell Death Quantification is Essential in Drug Development to Identify the Manner in Which Potential Drugs Could Inhibit Or Enhance Molecular Targets—A Key Factor Propelling Market Demand
6.2.2.5 Other Assay Kits
6.2.3 Probes & Labels
6.2.3.1 Effective Labeling of Cells Helps in Studying Cellular Events in A Spatial and Temporal Context - A Key Factor Driving the Demand for Probes and Labels
6.2.4 Microplates
6.2.4.1 Increasing Demand for Cell-Based Assays in Drug Discovery, Basic Research, and Preclinical Safety Studies is Encouraging the Consumption of Microplates
6.2.5 Cell Lines
6.2.5.1 Immortalized Cell Lines
6.2.5.1.1 Advantages of Immortalized Cell Lines Creating A Demand for These Cell Lines Over Primary and Stem Cell Lines
6.2.5.2 Primary Cell Lines
6.2.5.2.1 Primary Cell Lines are More Sensitive as Compared to Immortalized Cell Lines - A Key Factor Limiting Market Growth
6.2.5.3 Stem Cell Lines
6.2.5.3.1 Stem Cell Lines are Alternative Methodologies to Address the Cellularity Issues That Involve the Directed Differentiation of Embryonic Stem (Es) Cells Or Induced Pluripotent Stem Cells (Ips)
6.2.6 Other Consumables
6.3 Instruments
6.3.1 Biotechnology Companies Aim to Streamline Their Workflows to Improve Productivity and Reduce Costs, Which Will Drive the Growth of the Instruments Market
6.4 Services

7 Cell-Based Assays Market, By Application
7.1 Introduction
7.2 Drug Discovery
7.2.1 Toxicity Studies
7.2.1.1 Increasing Adoption of High-Content Screening for Evaluating Cytotoxicity is A Factor Stimulating the Use of Cell-Based Assays for Toxicity Studies
7.2.2 Pharmacokinetic Studies
7.2.2.1 Demand for Adme Studies to Rise Due to the Growing Need for Improved Clinical Success - A Major Factor Driving Growth
7.2.3 Pharmacodynamic Studies
7.2.3.1 Increasing Number of Pharmacodynamics Studies Globally to Drive Growth in the Cell-Based Assays Market
7.3 Basic Research
7.3.1 Increasing Funding By Government Institutes for Basic Research to Drive the Demand for Cell-Based Assay Products & Services
7.4 Other Applications

8 Cell-Based Assays Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 The Demand for Cell-Based Assays in This End-User Segment is Primarily Driven By the Growth in the Number of R&D Activities
8.3 Academic & Government Institutes
8.3.1 Increasing Interest of Academic Institutions to Develop Assays for Innovative Applications to Drive the Demand for Cell-Based Assays in This End-User Segment
8.4 Contract Research Organizations
8.4.1 Growth in Outsourcing to Drive the Demand for Cell-Based Assays in Contract Research Organizations

9 Cell-Based Assays Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Germany
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Market Ranking Analysis, 2017
10.2.1 Cell-Based Assays Market Ranking, By Key Player, 2017
10.3 Key Strategies
10.3.1 Product Launches, 2015–2018
10.3.2 Expansions, 2015–2018
10.3.3 Collaborations, 2015–2018:
10.3.4 Acquisitions, 2015–2018
10.4 Competitive Leadership Mapping (2017)
10.5 Visionary Leaders
10.6 Innovators
10.6.1 Dynamic Differentiators
10.6.2 Emerging Companies
10.7 Competitive Leadership Mapping for Start-Ups (2017)
10.7.1 Progressive Companies
10.7.2 Starting Blocks
10.7.3 Responsive Companies
10.7.4 Dynamic Companies

11 Company Profiles
11.1 Thermo Fisher Scientific Inc.
11.2 Danaher Corporation
11.3 Becton, Dickinson and Company
11.4 Ge Healthcare
11.5 Merck KGaA
11.6 Lonza Group Ltd.
11.7 Perkinelmer, Inc.
11.8 Charles River Laboratories, Inc.
11.9 Cell Signaling Technology, Inc.
11.10 Promega Corporation
11.11 Cisbio
11.12 Cell Biolabs, Inc.

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Subscription Portal
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables
Table 1 Market, By Product & Service, 2017–2024 (USD Million)
Table 2 Cell-Based Consumables Market, By Region, 2017–2024 (USD Million)
Table 3 Cell-Based Consumables Market, By Type, 2017–2024 (USD Million)
Table 4 Cell-Based Reagents Market, By Region, 2017–2024 (USD Million)
Table 5 Cell-Based Assay Kits Market, By Type, 2017–2024 (USD Million)
Table 6 Cell-Based Assay Kits Market, By Region, 2017–2024 (USD Million)
Table 7 Reporter Gene Assays Market, By Region, 2017–2024 (USD Million)
Table 8 Second Messenger Assays Market, By Region, 2017–2024 (USD Million)
Table 9 Cell Growth Assays Market, By Region, 2017–2024 (USD Million)
Table 10 Cell Death Assays Market, By Region, 2017–2024 (USD Million)
Table 11 Other Assay Kits Market, By Region, 2017–2024 (USD Million)
Table 12 Cell-Based Probes & Labels Market, By Region, 2017–2024 (USD Million)
Table 13 Cell-Based Microplates Market, By Region, 2017–2024 (USD Million)
Table 14 Cell Lines Market, By Type, 2017–2024 (USD Million)
Table 15 Cell Lines Market, By Region, 2017–2024 (USD Million)
Table 16 Immortalized Cell Lines Market, By Region, 2017–2024 (USD Million)
Table 17 Primary Cell Lines Market For, By Region, 2017–2024 (USD Million)
Table 18 Stem Cell Lines Market, By Region, 2017–2024 (USD Million)
Table 19 Other Consumables Market, By Region, 2017–2024 (USD Million)
Table 20 Cell-Based Instruments Market, By Region, 2017–2024 (USD Million)
Table 21 Cell-Based Assay Services Market, By Region, 2017–2024 (USD Million)
Table 22 Market, By Application, 2017–2024 (USD Million)
Table 23 Market for Drug Discovery, By Region, 2017–2024 (USD Million)
Table 24 Market for Drug Discovery, By Type, 2017–2024 (USD Million)
Table 25 Market for Toxicity Studies, By Region, 2017–2024 (USD Million)
Table 26 Market for Pharmacokinetic Studies, By Region, 2017–2024 (USD Million)
Table 27 Market for Pharmacodynamic Studies, By Region, 2017–2024 (USD Million)
Table 28 Market for Basic Research, By Region, 2017–2024 (USD Million)
Table 29 Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 30 Market, By End User, 2017–2024 (USD Million)
Table 31 Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 32 Market for Academic & Government Institutes, By Region, 2017–2024 (USD Million)
Table 33 Market for Contract Research Organizations, By Region, 2017–2024 (USD Million)
Table 34 Market, By Region, 2017–2024 (USD Million)
Table 35 North America: Market, By Country, 2017–2024 (USD Million)
Table 36 North America: Market, By Products & Services, 2017–2024 (USD Million)
Table 37 North America: Market, By Application, 2017–2024 (USD Million)
Table 38 North America: Market, By End User, 2017–2024 (USD Million)
Table 39 US: Market, By Products & Services, 2017–2024 (USD Million)
Table 40 US: Market, By Application, 2017–2024 (USD Million)
Table 41 US: Market, By End User, 2017–2024 (USD Million)
Table 42 Canada: Market, By Products & Services, 2017–2024 (USD Million)
Table 43 Canada: Market, By Application, 2017–2024 (USD Million)
Table 44 Canada: Market, By End User, 2017–2024 (USD Million)
Table 45 Europe: Market, By Country, 2017–2024 (USD Million)
Table 46 Europe: Market, By Products & Services, 2017–2024 (USD Million)
Table 47 Europe: Market, By Application, 2017–2024 (USD Million)
Table 48 Europe: Market, By End User, 2017–2024 (USD Million)
Table 49 UK: Market, By Products & Services, 2017–2024 (USD Million)
Table 50 UK: Market, By Application, 2017–2024 (USD Million)
Table 51 UK: Market, By End User, 2017–2024 (USD Million)
Table 52 Germany: Market, By Products & Services, 2017–2024 (USD Million)
Table 53 Germany: Market, By Application, 2017–2024 (USD Million)
Table 54 Germany: Market, By End User, 2017–2024 (USD Million)
Table 55 France: Market, By Product & Service, 2017–2024 (USD Million)
Table 56 France: Market, By Application, 2017–2024 (USD Million)
Table 57 France: Market, By End User, 2017–2024 (USD Million)
Table 58 RoE: Market, By Product & Service, 2017–2024 (USD Million)
Table 59 RoE: Market, By Application, 2017–2024 (USD Million)
Table 60 RoE: Market, By End User, 2017–2024 (USD Million)
Table 61 APAC: Market, By Country, 2017–2024 (USD Million)
Table 62 APAC: Market, By Product & Service, 2017–2024 (USD Million)
Table 63 APAC: Market, By Application, 2017–2024 (USD Million)
Table 64 APAC: Market, By End User, 2017–2024 (USD Million)
Table 65 China: Market, By Product & Service, 2017–2024 (USD Million)
Table 66 China: Market, By Application, 2017–2024 (USD Million)
Table 67 China: Market, By End User, 2017–2024 (USD Million)
Table 68 Japan: Market, By Product & Service, 2017–2024 (USD Million)
Table 69 Japan: Market, By Application, 2017–2024 (USD Million)
Table 70 Japan: Market, By End User, 2017–2024 (USD Million)
Table 71 India: Market, By Product & Service, 2017–2024 (USD Million)
Table 72 India: Market, By Application, 2017–2024 (USD Million)
Table 73 India: Market, By End User, 2017–2024 (USD Million)
Table 74 RoAPAC: Market, By Product & Service, 2017–2024 (USD Million)
Table 75 RoAPAC: Market, By Application, 2017–2024 (USD Million)
Table 76 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 77 RoW: Market, By Product & Service, 2017–2024 (USD Million)
Table 78 RoW: Market, By Application, 2017–2024 (USD Million)
Table 79 RoW: Market, By End User, 2017–2024 (USD Million)

List of Figures
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market: Bottom-Up Approach
Figure 4 Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Market, By Product & Service, 2019 vs 2024 (USD Million)
Figure 7 Market, By Application, 2019 vs 2024 (USD Million)
Figure 8 Market, By End User, 2019 vs 2024 (USD Million)
Figure 9 Market, By Region, 2019 vs 2024 (USD Million)
Figure 10 Growth in the Number of Drug Discovery Activities is Driving the Demand for Cell-Based Assays
Figure 11 Drug Discovery Applications Accounted for the Largest Share of the Cell-Based Assays: Market in 2018
Figure 12 Countries in APAC to Register A Higher Growth Rate During the Forecast Period
Figure 13 Cell-Based Assays: Market: Drivers, Restraints, and Opportunities
Figure 14 Consumables to Dominate the Cell-Based Assays: Market During the Forecast Period
Figure 15 Drug Discovery Applications to Witness the Highest Growth During the Forecast Period
Figure 16 Pharmaceutical & Biotechnology Companies Estimated to Be the Largest End Users of Cell-Based Assays During the Forecast Period
Figure 17 North America to Dominate the Cell-Based Assays: Market
Figure 18 North America: Cell-Based Assay Market Snapshot
Figure 19 APAC: Cell-Based Assays: Market Snapshot
Figure 20 Key Developments in the Cell-Based Assays: Market From 2015 to 2019
Figure 21 Dive-Vendor Comparison Matrix: Cell-Based Assays: Market
Figure 22 Dive-Vendor Comparison Matrix for Start-Ups: Cell-Based Assays: Market
Figure 23 Thermo Fisher Scientific Inc.: Company Snapshot (2017)
Figure 24 Danaher Corporation: Company Snapshot (2018)
Figure 25 Becton, Dickinson and Company: Company Snapshot (2018)
Figure 26 GE Healthcare: Company Snapshot (2018)
Figure 27 Merck KGaA: Company Snapshot (2017)
Figure 28 Lonza Group Ltd.: Company Snapshot (2017)
Figure 29 Perkinelmer, Inc.: Company Snapshot (2018)
Figure 30 Charles River Laboratories, Inc.: Company Snapshot (2017)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Becton, Dickinson and Company
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories, Inc.
  • Cisbio
  • Danaher Corporation
  • Ge Healthcare
  • Lonza Group Ltd.
  • Merck KGaA
  • Perkinelmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4760920
Adroll
adroll